Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine XL for Severe Preeclampsia Induction
NCT04392375Phase 4Completed
- Sponsor
- The Ohio State University
- Start
- Jun 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preeclampsia comparing Nifedipine 30MG with Placebo (2 arms). Primary endpoint: Number of Participants With the Change in Blood Pressure (Both Systolic and Diastolic) Under the Treatment of NIfedipine 30mg XL Versus Placebo. Started Jun 2020; status: completed.
02
Drugs
nifedipine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04392375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392375.